Skip to main content

Day: July 3, 2023

Trinity Biotech plc to Announce First Quarter Fiscal Year 2023 Financial Results

Conference Call Scheduled for July 6, 2023 at 11:00 am EASTERN DUBLIN, July 03, 2023 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2023 on Thursday, July 6, 2023. The Company has scheduled a conference call for that same day, July 6, 2023 at 11:00am ET (16:00pm BST) to discuss the results of the quarter.Interested parties can access the call by dialing:  US Toll Free:   1-844-861-5499  International Toll:  1-412-317-6581  Ireland Toll: 014311269  Ireland Toll Free:    1800932830Please ask to be joined into the Trinity Biotech call. A simultaneous webcast of the call can be accessed at:https://event.choruscall.com/mediaframe/webcast.html?webcastid=C83esXnKA...

Continue reading

Guggenheim Investments Announces July 2023 Closed-End Fund Distributions

NEW YORK, July 03, 2023 (GLOBE NEWSWIRE) — Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the “Funds” and each, a “Fund”). The following dates apply to the distributions:Record Date   July 14, 2023Ex-Dividend Date   July 13, 2023Payable Date   July 31, 2023Distribution ScheduleNYSE Ticker Closed-End Fund Name Distribution Per Share Change from Previous Distribution FrequencyAVK Advent Convertible and Income Fund $0.1172†   MonthlyGBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust $0.12573†   MonthlyGOF Guggenheim Strategic Opportunities Fund $0.1821†   MonthlyGUG Guggenheim Active Allocation Fund $0.11875†   Monthly† A portion...

Continue reading

CORRECTION: SYLA Announces 2023 Financial Guidance, Plan to Double Dividend Per Share

Net Revenues – (Unit: Million JPY) Net Revenues – (Unit: Million JPY)Income from Operation – (Unit: Million JPY) Income from Operation – (Unit: Million JPY)Earnings Per Share – (Unit: JPY) Earnings Per Share – (Unit: JPY)Dividend Per Share – (Unit: JPY) Dividend Per Share – (Unit: JPY)TOKYO, July 03, 2023 (GLOBE NEWSWIRE) — SYLA Technologies Co., Ltd. (“SYLA” or “the Company”), operator of the largest membership real estate crowd-funding platform in Japan, Rimawari-kun, today announced financial guidance for the full-year 2023, and a plan to double the dividend per share (1 share = 100 ADRs) from ¥70 ($0.52) per share to ¥140 ($1.04) per share for the year ending December 31, 2023, compared to 2022. Guidance for Full Year 2023Revenue is expected to be between ¥24,700...

Continue reading

Tenaris Completes Acquisition of Additional Participation in Usiminas Control Group

LUXEMBOURG, July 03, 2023 (GLOBE NEWSWIRE) — Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) reported today that its Brazilian subsidiary Confab Industrial S.A., together with its affiliates Ternium Investments and Ternium Argentina, all of which compose the T/T group within the Usiminas control group, completed the previously announced acquisition of 68.7 million ordinary shares of Usinas Siderúrgicas de Minas Gerais S.A. – USIMINAS (“Usiminas”) from Nippon Steel Corporation, Mitsubishi and MetalOne (the “NSC group”), pro rata to their current participations in the T/T group within the Usiminas control group, at a price of BRL 10 per ordinary share. Pursuant to the transaction, Tenaris paid approximately BRL 110 million (approximately USD 23 million) in cash for 11.0 million ordinary shares, increasing its participation...

Continue reading

ARYA Sciences Acquisition Corp V will redeem its Class A Ordinary Shares and will not consummate an initial business combination

NEW YORK, July 03, 2023 (GLOBE NEWSWIRE) — ARYA Sciences Acquisition Corp V (the “Company”) (Nasdaq: ARYE), a special purpose acquisition company, today announced that as of the close of business on July 14, 2023, the Company’s publicly held Class A ordinary shares, par value $0.0001 (the “Public Shares”), will be deemed cancelled and will represent only the right to receive their pro-rata share in the Company’s trust account (“Trust Account”), because the Company will not consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association (the “Articles”). As stated in the Company’s Articles and in the Company’s registration statement on Form S-1 (Registration No. 333-257335), initially filed with the United States Securities and Exchange Commission (the...

Continue reading

Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to August 3, 2023

MIAMI, July 03, 2023 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose acquisition company, announced today that its sponsor, Vision Sensing, LLC, deposited $72,562.86 into the Company’s trust account on June 30, 2023, which is the sum that the Company must pay to extend the date by which the Company must consummate its initial business combination from July 3, 2023 to August 3, 2023 (the “Extension”). The Company has issued to its sponsor a non-interest bearing, unsecured promissory note in the principal amount of $72,562.86 as consideration for the funding. This is the third of up to six one-month extensions that the Company is authorized to obtain under its amended and restated certificate of incorporation as recently amended on May 1, 2023. The Extension provides...

Continue reading

Integra LifeSciences to Host Second Quarter 2023 Financial Results Conference Call on July 27, 2023

PRINCETON, N.J., July 03, 2023 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2023 financial results on Thursday, July 27, 2023, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call. About Integra LifeSciences At Integra...

Continue reading

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at June 30, 2023

HOUSTON, Texas, July 03, 2023 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of June 30, 2023. As of June 30, 2023, the Company’s net assets were $1.3 billion, and its net asset value per share was $9.79. As of June 30, 2023, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 591% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 428%. Kayne Anderson Energy Infrastructure Fund, Inc.Statement of Assets and LiabilitiesJune 30, 2023(Unaudited)    (in...

Continue reading

Kayne Anderson NextGen Energy & Infrastructure Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at June 30, 2023

HOUSTON, July 03, 2023 (GLOBE NEWSWIRE) — Kayne Anderson NextGen Energy & Infrastructure, Inc. (the “Fund”) (NYSE: KMF) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of June 30, 2023. As of June 30, 2023, the Fund’s net assets were $403.3 million and its net asset value per share was $8.54. As of June 30, 2023, the Fund’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 655% and the Fund’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 432%.Kayne Anderson NextGen Energy & Infrastructure, Inc.      Statement of Assets and Liabilities      June 30, 2023      (Unaudited)          (in...

Continue reading

Mondelēz Global LLC Conducts Voluntary Recall of Two Varieties of belVita Breakfast Sandwich Products Sold in the United States Due to Undeclared Peanut Allergen

belVita Breakfast Sandwich Cinnamon Brown Sugar with Vanilla Creme belVita Breakfast Sandwich Cinnamon Brown Sugar with Vanilla CremebelVita Breakfast Sandwich Dark Chocolate Creme belVita Breakfast Sandwich Dark Chocolate CremeEAST HANOVER, N.J., July 03, 2023 (GLOBE NEWSWIRE) — Mondelēz Global LLC announced today a voluntary recall of two varieties of belVita Breakfast Sandwich products, manufactured in the United States and sold nationwide, due to the possibility that the products may contain undeclared peanut resulting from cross-contact on a single manufacturing line. People who have an allergy or severe sensitivity to peanut may risk serious or life-threatening allergic reactions by consuming these products. This recall is limited exclusively to the belVita Breakfast Sandwich products listed in the grid below, available...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.